Natalie Fadle

Homburg, SL, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

Neutralizing autoantibodies against IL-1Ra in severe bacterial community-acquired pneumonia.

Neutralizing autoantibodies against IL-1Ra in severe bacterial community-acquired pneumonia.

Journal: The Journal of allergy and clinical immunology

Published: April 28, 2026

IL-1 Receptor Antagonist Antibodies in Idiopathic Recurrent Pericarditis.

IL-1 Receptor Antagonist Antibodies in Idiopathic Recurrent Pericarditis.

Journal: JAMA network open

Published: October 09, 2025

Autoantibodies to IL-1Ra and PGRN in severe COVID-19 are associated with inflammation-induced hyperphosphorylated antigen isoforms.

Autoantibodies to IL-1Ra and PGRN in severe COVID-19 are associated with inflammation-induced hyperphosphorylated antigen isoforms.

Journal: Nature communications

Published: March 13, 2025

Anakinra during pregnancy and lactation for corticosteroid-dependant colchicine-resistant recurrent pericarditis in a patient with neutralizing anti-interleukin-1 receptor antagonist antibodies: a case report.

Anakinra during pregnancy and lactation for corticosteroid-dependant colchicine-resistant recurrent pericarditis in a patient with neutralizing anti-interleukin-1 receptor antagonist antibodies: a case report.

Journal: European heart journal. Case reports

Published: January 03, 2025

Autoantibody mediated deficiency of IL-36-receptor antagonist in a subset of patients with psoriasis and psoriatic arthritis.

Autoantibody mediated deficiency of IL-36-receptor antagonist in a subset of patients with psoriasis and psoriatic arthritis.

Journal: Immunology letters

Published: June 04, 2024

Hyper-N-glycosylated SEL1L3 as auto-antigenic B-cell receptor target of primary vitreoretinal lymphomas.

Hyper-N-glycosylated SEL1L3 as auto-antigenic B-cell receptor target of primary vitreoretinal lymphomas.

Journal: Scientific reports

Published: December 05, 2023

Autoantibody-Mediated Depletion of IL-1RA in Still's Disease and Potential Impact of IL-1 Targeting Therapies.

Autoantibody-Mediated Depletion of IL-1RA in Still's Disease and Potential Impact of IL-1 Targeting Therapies.

Journal: Journal of clinical immunology

Published: August 17, 2023

B-cell receptor reactivity against Rothia mucilaginosa in nodular lymphocyte-predominant Hodgkin lymphoma.

B-cell receptor reactivity against Rothia mucilaginosa in nodular lymphocyte-predominant Hodgkin lymphoma.

Journal: Haematologica

Published: January 23, 2023

Autoantibodies against SUMO1-DHX35 in long-COVID.

Autoantibodies against SUMO1-DHX35 in long-COVID.

Journal: Journal of translational autoimmunity

Published: November 13, 2022

Ars2-containing bispecific, Fab- and IgG1-format BAR-bodies to target DLBCL cells.

Ars2-containing bispecific, Fab- and IgG1-format BAR-bodies to target DLBCL cells.

Journal: EJHaem

Published: September 30, 2022

IL-1RA Antibodies in Myocarditis after SARS-CoV-2 Vaccination.

IL-1RA Antibodies in Myocarditis after SARS-CoV-2 Vaccination.

Journal: The New England journal of medicine

Published: September 21, 2022

Autoantibodies against interleukin-1 receptor antagonist in multisystem inflammatory syndrome in children: a multicentre, retrospective, cohort study.

Autoantibodies against interleukin-1 receptor antagonist in multisystem inflammatory syndrome in children: a multicentre, retrospective, cohort study.

Journal: The Lancet. Rheumatology

Published: April 04, 2022

Showing 1-12 of 33

Last Updated: 09/26/2026